Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: The necessity of repeated molecular analysis

  1. González-Larriba, J.L.
  2. Lázaro-Quintela, M.
  3. Cobo, M.
  4. Dómine, M.
  5. Majem, M.
  6. García-Campelo, R.
Revista:
Translational Lung Cancer Research

ISSN: 2226-4477 2218-6751

Ano de publicación: 2017

Volume: 6

Páxinas: S21-S34

Tipo: Revisión

DOI: 10.21037/TLCR.2017.10.03 GOOGLE SCHOLAR

Obxectivos de Desenvolvemento Sustentable